AQAL Integral Investing
VC Fund
Munich, Germany
AQAL Integral Investing is a VC fund in Munich focused on Health Care and Medical Device. AQAL Capital invests in state-of-the-art exponential technology companies which have the potential for integral impact, including substantial growth, while implementing the UN SDGs within the Planetary Boundaries.We focus on seed and early-stage companies. Their leadership team must be strong, their technology must be proven, and should have ashort runway to cash flow break-even.Our regional focus is the European Union with the main emphasis on DACH (Germany, Austria, Switzerland). A few selected investments are also made in the San Francisco Bay Area.According to our Integral Investing philosophy, the business models of our investees must be transferable to other countries, be scalable to market leadership, and deliver sustainable and risk-adjusted returns on multiple bottom lines as defined by our 6Ps: Parity of People, Planet, and Profit — with Passion and Purpose.Given our investing expertise, background, and entrepreneurial experience, we are focusing on three main sectors of innovation for life in the 21st century:Exponential Technology & Digital Evolution: Internet Infrastructure, Artificial Intelligence, B2B IT Solutions, Digital Design Green Technology: Renewable Energy, Energy Efficiency, CleanTech, Circular Economy Life in the 21st century: Future Mobility, Nutrition & Agro, Med Tech, Media & Entertainment Tech
- Total investments:
- 12
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries AQAL Integral Investing invests in
Stages AQAL Integral Investing invests in
Countries AQAL Integral Investing invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.5M–$1.5M
Investment Focus
Industry
- Health Care 4 (33%)
- Medical Device 3 (25%)
- Medical 2 (17%)
- Biotechnology 2 (17%)
- Information Technology 2 (17%)
Stage
- Seed 8 (67%)
- Angel 1 (8%)
- Pre-Seed 1 (8%)
- Venture - Series Unknown 1 (8%)
Country
- Germany 6 (50%)
- United States 2 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Mariana Bozesan
Founder & Partner
|
Founder & Partner | Total investments: 1 | Find email | |
Tom Schulz
Co-founder & Managing Partner
|
Co-founder & Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DNTOX
|
We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments! | $1.5M / Seed / Jun 14, 2023 | |
wondder
|
Wondder is a virtual reality and ethical artificial intelligence training company. | $538.1K / Angel / Jun 12, 2023 | |
|
wondder
|
Wondder is a virtual reality and ethical artificial intelligence training company. | Seed / Mar 06, 2023 | |
|
DNTOX
|
We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments! | Seed / Feb 14, 2023 | |
|
wondder
|
Wondder is a virtual reality and ethical artificial intelligence training company. | Pre-Seed / Jan 01, 2023 | |
Elona Health
|
Elona Health develops digital health application to support treatment for patients and therapists alike. | Seed / Nov 01, 2022 | |
cureVision
|
cureVision is an AI-based medical imaging and diagnostic solutions for vascular surgeons and care staff, specialist for chronic wounds. | $1.5M / Seed / Oct 22, 2022 | |
Tembo Health
|
Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans. | Seed / Sep 15, 2022 | |
|
Tembo Health
|
Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans. | Venture - Series Unknown / Aug 15, 2022 | |
PhysioCue
|
PhysioCue is a medical device company that has developed anti-hypertensive and migraine/headache medical devices which have been clinically proven to immediately reduce the high blood pressure of hypertensive patients and shown to relieve migraine/headache pain. These devices are non-invasive and work by controlled cold therapy to triggerthe carotid artery baroreceptor reflex. Unlike drug treatments and invasive procedures, their PhysioCue therapy is efficient, safe, easy to use, and has none of the side effects associated with anti-hypertensive drugs. PhysioCue is also developing a wearable mobile health device. | Seed / Mar 18, 2019 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does AQAL Integral Investing invest in?
AQAL Integral Investing invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Angel stage. Most of the 12 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is AQAL Integral Investing's check size?
AQAL Integral Investing typically joins rounds of $1.5M–$1.5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds AQAL Integral Investing participates in.
How do I contact AQAL Integral Investing?
Public channels for AQAL Integral Investing include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at AQAL Integral Investing?
The team at AQAL Integral Investing includes Mariana Bozesan (Founder & Partner) and Tom Schulz (Co-founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
